| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| May 5, 2026 | ±2.9% | +3.3% | under-priced |
| November 4, 2025 | ±2.1% | +10.8% | under-priced |
| August 5, 2025 | ±2.5% | -7.4% | under-priced |
| May 5, 2025 | ±2.5% | +2.0% | over-priced |
| November 5, 2024 | ±1.9% | -4.6% | under-priced |
| August 6, 2024 | ±3.6% | -8.1% | under-priced |
| May 7, 2024 | ±2.7% | +3.9% | under-priced |
| November 28, 2023 | ±1.6% | -0.8% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $0.92 | $3.4B | $112M |
| Q3 FY2025 | $0.84 | $3.3B | $109M |
| Q2 FY2025 | $0.70 | $3.2B | $94M |
| Q1 FY2025 | $0.88 | $3.2B | $113M |
Henry Schein Inc (HSIC) reports in 97 days, with the next report estimated for September 18, 2026. Across the last 8 reports, options priced an average ±2.5% earnings move while the stock actually moved 5.1% on average — the market has tended to under-price HSIC's earnings risk. Fundamentals into the print: EPS up 22.7% year-over-year, revenue up 5.5%. QuantLogix's live 5-factor engine currently reads HSIC as a buy at 62/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →